Journal
CLINICAL INFECTIOUS DISEASES
Volume 70, Issue 3, Pages 538-542Publisher
OXFORD UNIV PRESS INC
DOI: 10.1093/cid/ciz545
Keywords
procalcitonin; pneumonia; sensitivity; specificity
Categories
Ask authors/readers for more resources
Because of the diverse etiologies of community-acquired pneumonia (CAP) and the limitations of current diagnostic modalities, serum procalcitonin levels have been proposed as a novel tool to guide antibiotic therapy. Outcome data from procalcitonin-guided therapy trials have shown similar mortality, but the essential question is whether the sensitivity and specificity of procalcitonin levels enable the practitioner to distinguish bacterial pneumonia, which requires antibiotic therapy, from viral pneumonia, which does not. In this meta-analysis of 12 studies in 2408 patients with CAP that included etiologic diagnoses and sufficient data to enable analysis, the sensitivity and specificity of serum procalcitonin were 0.55 (95% confidence interval [CI],.37-.71; I-2 = 95.5%) and 0.76 (95% CI,.62-.86; I-2 = 94.1%), respectively. Thus, a procalcitonin level is unlikely to provide reliable evidence either to mandate administration of antibiotics or to enable withholding such treatment in patients with CAP.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available